Skip to main content


Mantle Cell Lymphoma

Featured

News
KTE-X19 is a potentially cost-effective alternative to the current standard of care for relapsed/refractory MCL.
Quiz
True or False: Positive MRD status after induction and consolidation treatments for patients with MCL is associated…
Quiz
True of False: MRD status prior to autologous stem cell transplantation is an early predictor of PFS and OS in younger…
News
Older patients with MCL have a high rate of comorbidities impacting treatment choices and OS.
News
Positive MRD status after induction and consolidation treatments for patients with MCL is associated with worse PFS and…
Back to Top